Dr. Reddy's Laboratories Ltd receives EIR for Bachupally Plant-3

Dr. Reddy's Laboratories Ltd. has announced in reference to the audit of its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad. The company has received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit.

Shares of DR.REDDY's LABORATORIES LTD. was last trading in BSE at Rs.3710.2 as compared to the previous close of Rs. 3677.6. The total number of shares traded during the day was 20181 in over 2480 trades.

The stock hit an intraday high of Rs. 3723.6 and intraday low of 3663.15. The net turnover during the day was Rs. 74615956.

Source : Equity Bulls

Keywords